Zink, Mathias <br/><br/>
Glutamatergic agents for schizophrenia: current evidence and perspectives.  [electronic resource] 

 -  Expert review of clinical pharmacology  May 2015 
 - 335-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1751-2441 
<br/><br/><label>Standard No.: </label>10.1586/17512433.2015.1040393  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antipsychotic Agents--administration & dosage<br/>Cognition Disorders--drug therapy<br/>Dopamine--metabolism<br/>Dose-Response Relationship, Drug<br/>Excitatory Amino Acid Agents--administration & dosage<br/>Glutamic Acid--metabolism<br/>Humans<br/>Patient Selection<br/>Schizophrenia--drug therapy<br/>Schizophrenic Psychology<br/>Treatment Outcome